Liquid Biopsy Market

1
Liquid Biopsy Market
Category Diagnostics Market Report
2
Liquid Biopsy Market Analyst View Liquid
Biopsy Market is projected to exceed US 3.4
Billion by the year 2024. Get Free
Customization in this Report Research Report
Title Liquid Biopsy Market, Global Analysis by
Cancer (Lung Cancer, Breast Cancer, Colorectal
Cancer, Prostate Cancer Others), Product (Kits
Consumables, Instruments and Services),
Circulating Biomarkers (Circulating Tumor Cells
(CTCs), Circulating Tumor DNA (ctDNA)
Exosomes), Sample (Plasma/Serum, Urine Others),
Clinical Application (Monitoring, Prognosis,
Theranostics Screening), Regions (North
America, Europe, Asia-Pacific, Latin America and
Middle East/Africa), Companies (Thermo Fisher
Scientific Inc., Roche Diagnostics, Bio-Rad
Laboratories Inc., Biocept Inc., Biocartis,
Myriad Genetics Inc., Genomic Health, NeoGenomics
Laboratories, Qiagen)

3
Liquid Biopsy Market is projected to exceed US
3.4 Billion by the year 2024.
Access Full Research https//www.renub.com/liqui
d-biopsy-market-p.php Get Free Customization in
this Report As per Renub Research analysis Liquid
Biopsy Market is projected to exceed US 3.4
Billion by the year 2024, witnessing the
worldwide increasing prevalence of cancer and
raising awareness regarding the minimal invasive
liquid biopsy technology across the world. Today,
liquid biopsy has paved the road of cancer
diagnosis and treatment by offering a complete
treatment response in real time without the need
of serial traditional (solid-tissue)
biopsies. Today, the population across the globe
is growing and aging and so is the global burden
of cancer it is estimated that by the year 2030,
the global cancer burden will reach nearly 21.7
Million new cancer cases and be around 13 Million
cancer deaths. It is also expected that the low
and middle income countries accounts for 60 of
the cancer deaths due to the lack of medical
resources and proper healthcare systems.

4
Liquid Biopsy Market is projected to exceed US
3.4 Billion by the year 2024.
Request a free sample copy of the
report https//www.renub.com/contactus.php   The
cases of cancer increases very rapidly around the
world owing to the adoption of unhealthy
lifestyles and behaviors such as smoking, poor
diet, physical inactivity etc. These rising cases
of cancer will drive the liquid biopsy market to
thrive in the coming years. As liquid biopsy is a
simple and non-invasive technique it enables
physicians to discover a range of information
about patients tumor and provide clues about the
treatment that a patients needs. Renub
Research report titled Liquid Biopsy Market, by
Cancer (Lung Cancer, Breast Cancer, Colorectal
Cancer, Prostate Cancer Others), Product (Kits
Consumables, Instruments and Services),
Circulating Biomarkers (Circulating Tumor Cells
(CTCs), Circulating Tumor DNA (ctDNA)
Exosomes), Sample (Plasma/Serum, Urine Others),
Clinical Application (Monitoring, Prognosis,
Theranostics Screening), Regions (North
America, Europe, Asia-Pacific, Latin America and
Middle East/Africa), Companies (Thermo Fisher
Scientific Inc., Roche Diagnostics, Bio-Rad
Laboratories Inc., Biocept Inc., Biocartis,
Myriad Genetics Inc., Genomic Health, NeoGenomics
Laboratories, Qiagen) provides a complete
analysis of Global Liquid Biopsy Market.

5
Liquid Biopsy Market is projected to exceed US
3.4 Billion by the year 2024.

6
Liquid Biopsy Market is projected to exceed US
3.4 Billion by the year 2024.
By Cancer Lung Cancer Controls the Liquid
Biopsy Market The report studies the market of
the following cancer segments Lung Cancer,
Breast Cancer, Colorectal Cancer, Prostate Cancer
Others. Lung cancer and Breast cancer together
accounts for the considerable market share in the
global liquid biopsy market. By Product
Majority of Liquid Biopsy Market held by Kits
Consumables  The report studies the market of the
following product segments Kits consumables,
Instruments and Services. More than 90 of liquid
biopsy market is comprised by kits Consumables
and Instruments. By Circulating Biomarkers  The
report studies the liquid biopsy market by
Circulating Tumor Cells (CTCs), Circulating Tumor
DNA (ctDNA) Exosomes. Circulating Tumor Cells
(CTCs) and Circulating Tumor DNA (ctDNA) together
holds significant market share By Sample
Plasma/Serum accounts for the maximum market  In
terms of Sample used for liquid biopsy, the
global liquid biopsy market has been studied as
Plasma/Serum, Urine and Others.

7
Liquid Biopsy Market is projected to exceed US
3.4 Billion by the year 2024.
By Region North America Europe will drive the
Liquid Biopsy Market North America and Europe
together controls the Liquid Biopsy Market. In
addition the report also provides the complete
geographical analysis of Asia-Pacific, Latin
America and Middle East/Africa Liquid Biopsy
Market. Companies Analysis Thermo Fisher
Scientific Inc., Roche Diagnostics, Bio-Rad
Laboratories Inc., Biocept Inc., Biocartis,
Myriad Genetics, Inc., Genomic Health,
NeoGenomics Laboratories, Qiagen which has been
studied thoroughly in the report.   Client can
Purchase this Report in Sections from below
link Access full Research https//www.renub.co
m/liquid-biopsy-market-p.php  All the 9
Companies Studied in Report have been Studied
from 3 Points      Company Overview      
 Product Portfolio    Financial Insight

8
Liquid Biopsy Market is projected to exceed US
3.4 Billion by the year 2024.
This market research report provides a complete
analysis of the Liquid Biopsy Market, Growth
Drivers, Challenges, and their projections for
the upcoming years. By Cancer      Lung
Cancer     Breast Cancer     Colorectal
Cancer    Prostate Cancer     Others   By
Product     Kits Consumables   
 Instruments    Services By Circulating
Biomarkers     Circulating Tumor Cells
(CTCs)     Circulating Tumor DNA (ctDNA)  
 Exosomes By Sample      Plasma/Serum   
 Urine     Others

9
Liquid Biopsy Market is projected to exceed US
3.4 Billion by the year 2024.
By Clinical Application     Monitoring   
 Prognosis    Theranostics     Screening By
Regions     North America     Europe  
 Asia-Pacific      Latin America    Middle
East/Africa By Companies     Thermo Fisher
Scientific Inc.     Roche Diagnostics  
 Bio-Rad Laboratories Inc.     Biocept Inc.  
 Biocartis     Myriad Genetics, Inc.  
 Genomic Health     NeoGenomics
Laboratories    Qiagen

10
Table of Contents for Liquid Biopsy Market
Key Topics Covered 1.    Executive Summary 2.  
 Global - Liquid Biopsy Market 3.    Market
Share Global Liquid Biopsy 3.1    By
Region 3.2    By Cancer3.3    By
Product 3.4    By Circulating Biomarkers 4. 
  Region - Liquid Biopsy Market 4.1    North
America 4.2    Europe4.3    Asia-Pacific 4.4  
 Latin America4.5    Middle East Africa 5.  
 Cancer - Liquid Biopsy Market 5.1    Lung
Cancer 5.2    Breast Cancer5.3    Colorectal
Cancer 5.4    Prostate Cancer5.5    Others

11
Table of Contents for Liquid Biopsy Market
6.    By Product - Liquid Biopsy Market 6.1  
 Kits Consumables 6.2    Instruments6.3  
 Services 7.    Circulating Biomarkers - Liquid
Biopsy Market 7.1    Circulating Tumor Cells
(CTCs) 7.2    Circulating Tumor DNA (ctDNA)7.3  
 Exosomes 8.    By Clinical Application - Liquid
Biopsy Market 8.1    Monitoring 8.2  
 Prognosis8.3    Theranostics 8.4  
 Screening 9.    By Sample - Liquid Biopsy
Market 9.1    Plasma / Serum 9.2    Urine9.3  
 Others 10.    Thermo Fisher Scientific Inc
Company Analysis 10.1    Product Portfolio

12
Table of Contents for Liquid Biopsy Market
11    Roche Diagnostics Company Analysis 11.1  
 Product Portfolio 12.    Bio-Rad Laboratories
Inc Company Analysis 12.1    Product
Portfolio 13.    Biocept, Inc. Company
Analysis 13.1    Product Portfolio 13.2  
 Financial Insight 14.    Biocartis Company
Analysis 14.1    Product Portfolio 14.2  
 Financial Insight 15.    Myriad Genetics, Inc
Company Analysis 15.1    Product
Portfolio 15.2    Financial Insight 16.  
 Genomic Health Company Analysis 16.1  
 Product Portfolio 16.2    Financial
Insight 17.    NeoGenomics Laboratories
Company Analysis 17.1    Product
Portfolio 17.2    Financial Insight

13
Table of Contents for Liquid Biopsy Market
18.    Qiagen Company Analysis 18.1    Product
Portfolio18.2    Financial Insight 19.  
 Growth Drivers 19.1    Real-Time Evaluation,
Convenient and Accuracy19.2    Increasing Demand
for Minimally-Invasive Biopsy Techniques19.3  
 Technical Advancement Personalized
Therapies 20.    Challenges 20.1    Barriers for
Liquid Biopsies20.2    High Cost with Uncertain
or Limited Reimbursement for Liquid Biopsy

14
Get Free Customization in this Report
Diagnostics Market Reports https//www.renub.
com/diagnostics-14-c.php
Renub Research - North America Rajat Gupta 225 Kristie Ln, Roswell Georgia 30076, United States Tel [phone] Email info_at_renub.com www.renub.com Renub Research - Asia Ankit Mishra C 86, Sector 10 Noida 201301, India Tel [phone] Email info_at_renub.com www.renub.com